Service d’Urologie
UroCCR
Digital Urology 3D
Fonds de recherche et innovation en chirurgie rénale
Robotic Training Center
BRIC équipe émergente
Effects of a personalized or generic three-dimensional tumoral kidney model on patient experience and caregiver-patient interactions, before and after partial nephrectomy, a randomized trial (Rein 3D Print Personalize-UroCCR 114) Pattou M, Masanet S, Jutand MA, et al.
Assessing Oncologic and Functional Outcomes of 3D Image-Guided Robotic-Assisted Partial Nephrectomy (3D-IGRAPN): A Prospective Study (UroCCR-186). Pitout A, Margue G, Rubat Baleuri F, Khaddad A, Pattou M, Bladou F, Robert G, Bernhard J-C.
Improving the Accuracy and Repeatability of Renal Stiffness Measurement With Magnetic Resonance Elastography: Influence of Vibration Frequency, Acquisition Orientation, and Postprocessing-A Phantom and Volunteer Study. Jambon E, Courtine C, Soulabaille B, et al.
Effect on preoperative anxiety of a personalized three-dimensional kidney model prior to nephron-sparing surgery for renal tumor: study protocol for a randomized controlled trial (Rein 3D Print-Anxiety - UroCCR 113). Pitout A, Margue G, Sarrazin J, et al.
Clinical Trial Protocol for ACCURATE: A CCafU-UroCCR Randomized Trial: Three-dimensional Image-guided Robot-assisted Partial Nephrectomy for Renal Complex Tumor (UroCCR 99). Margue G, Bernhard JC, Giai J, et al.
Effect of obesity on histological type of renal tumor: The Uroccr study 69 Montalvan L, Bernhard JC, Bensalah K, et al.
Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulationEmanuelli A, Souleyreau W, Chouleur T, et al.
Investigation of whether renal tumours with caval thrombi induce particular risks: a multicentre study (UroCCR-174 CAVORISK) Panis A, Waeckel T, Bensalah K, et al.
Value of the urine culture and antibiotic prophylaxis before partial nephrectomy in cancer (UroCCR n°107 - NephroBacte) Bruyere F, Vallée M, Bernhard JC, et al.
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study). Binzaqr S, Kryza D, Giraudet AL, et al.
Collecting Duct Carcinoma: Characteristics and Survival Outcomes From UroCCR Database (CDCSurv UroCCR n°141). Le Mével LP, Bernhard JC, Yacoub M, et al.
Renal Mass Biopsy Prior to Surgical Excision: Practice, Diagnostic Performance, and Impact on Management in the UroCCR Registry (Ancillary Study No. 118). Proye P, Gondran-Tellier B, Michel F, et al.
Efficacy of immune checkpoint inhibitors in renal cell carcinoma venous tumour thrombus shrinkage (UroCCR 128) Moinard-Butot F, Thouvenin J, Bigot P, et al.
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma Pignot G, Margue G, Bigot P, et al.
SAFE: Multi-institutional study of time to complications after robot-assisted partial nephrectomy, selection of a population eligible for outpatient management (UroCCR 90) Barthe F, Bentellis I, Bernhard JC, et al.
Aller au contenu
